InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
3
T+90 hit rate
23%
T+90 mean return
-23.1%
Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Burrell Terry-Ann, Chief Financial Officer. Director active across 2 companies, notably Beam Therapeutics Inc.. Cumulatively, 29 filings have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €476k. Activity tracked since 28 June 2021. The latest transaction was disclosed on 1 July 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations29 total
1,843 shares0Class A Common StockSEC:0001601830-24-000097:0
13,097 shares0Class A Common StockSEC:0001601830-24-000073:0
12,500 shares0Common StockSEC:0000950170-24-049854:0
1,467 shares0Class A Common StockSEC:0001601830-24-000028:0
5,446 shares@ US$32.126.4% of flowCommon StockSEC:0000950170-24-041437:0
27,500 shares0Common StockSEC:0000950170-24-040154:0
24,302 shares@ US$11.2501100.0% of flowClass A Common StockSEC:0001209191-23-042305:0
12,612 shares0Class A Common StockSEC:0001209191-23-038838:0
2,454 shares@ US$30.312.7% of flowCommon StockSEC:0000899243-23-010815:0
20,000 shares0Common StockSEC:0000899243-23-010132:0
1,102 shares@ US$13.680.5% of flowCommon StockSEC:0000899243-23-002957:0
5,426 shares@ US$13.682.7% of flowCommon StockSEC:0000899243-23-002666:0
39,886 shares@ US$13.6819.9% of flowCommon StockSEC:0000899243-23-002260:0
1,821 shares0Class A Common StockSEC:0001209191-23-002059:0
1,265 shares0Class A Common StockSEC:0001209191-22-052911:0
1,631 shares0Class A Common StockSEC:0001209191-22-041276:0
18,145 shares0Class A Common StockSEC:0001209191-22-037631:0
1,788 shares0Class A Common StockSEC:0001209191-22-023316:0
15,000 shares0Common StockSEC:0000899243-22-013485:0
763 shares0Class A Common StockSEC:0001209191-22-002050:0
763 shares0Class A Common StockSEC:0001209191-22-002050
629 shares0Class A Common StockSEC:0001209191-21-059745
629 shares0Class A Common StockSEC:0001209191-21-059745:0
382 shares0Class A Common StockSEC:0001209191-21-045551
382 shares0Class A Common StockSEC:0001209191-21-045551:0
25 of 29 declarations
About Burrell Terry-Ann
Terry-Ann Burrell serves as Chief Financial Officer and Board Member at Beam Therapeutics Inc. and RECURSION PHARMACEUTICALS, INC. She is responsible for strategic financial management and overseeing the financial operations of the companies. Her expertise in finance is crucial for the growth and sustainability of the organizations.
